Beate Quednau und Amgen - Info zur Person

(1 - 12 von 13

)

Trebananib (AMG 386) plus weekly paclitaxel with or without ...ur.booksc.org › book

ur.booksc.org

... (Complete Healthcare Communications, Inc.), whose work was funded by Amgen Inc., and Beate Quednau, PhD (Amgen Inc.), for medical writing assistance.

Europe PMC

europepmc.org

The authors acknowledge Beate Quednau, PhD (Amgen Inc., Thousand Oaks, CA), and Erica Chevalier-Larsen and Diane Warner (Complete Healthcare ...

The effect of different dosing regimens of motesanib on the...

bmccancer.biomedcentral.com

· ... Inc., Chadds Ford, PA, USA), whose work was funded by Amgen Inc., and Beate Quednau (Amgen Inc.) for assistance in manuscript writing.

Safety and Pharmacokinetics of Motesanib in Combination with...

www.hindawi.com

... Communications Inc.), whose work was funded by Amgen Inc., and Beate Quednau, Ph.D. (Amgen, Inc.), for assistance in the preparation of this paper.

Motesanib inhibits Kit mutations associated with gastrointestinal...

link.springer.com

... Inc.), whose work was funded by Amgen Inc., and Beate Quednau, PhD (Amgen Inc.), for their assistance in the preparation of this manuscript ...

Antitumor activity of motesanib alone and in BioMedSearchwww.biomedsearch.com/attachments pdf

www.biomedsearch.com

work was funded by Amgen Inc., and Beate Quednau, PhD (Amgen Inc.), for assistance in writing this manuscript. Additionally, the authors ...

Safety and pharmacokinetics of motesanib in Dimensionsapp.dimensions.ai › publication › pub

app.dimensions.ai

... and Ali Hassan, Ph D (Complete Healthcare Communications Inc.), whose work was funded by Amgen Inc., and Beate Quednau, Ph D (Amgen Inc.), ...

Long-term follow-up of serum immunoglobulin levels in...

www.nature.com

... and Beate Quednau, PhD (Amgen Inc.). This study was funded by Amgen Inc. and is registered with ClinicalTrials.gov (identifier, NCT ).

Alle Infos zum Namen "Beate Quednau"

AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic...

findanexpert.unimelb.edu.au

Ben Scott, PhD (Scott Medical Communications, LLC), and Beate Quednau, PhD (Amgen Inc.), provided medical writing assistance funded by Amgen Inc.

Amgen Inc employees: Berlingeri, Shin-Kashiyama, Sickmier

bearsofficialsstore.com

Profiles of all 1,487 Amgen Inc employees: Carlos Berlingeri, Erika Shin-Kashiyama, Allen Sickmier, Nisan Steinberg, Nancy L Chapman MS-IS PMP, Milan Petkovic

Anti-angiopoietin therapy with trebananib for recurrent ovarian ...mdanderson.elsevierpure.com › publications › anti-a...

mdanderson.elsevierpure.com

We thank Zhandong Don Zhong (Amgen) for doing the anti-trebananib antibody analysis; and Beate Quednau (Amgen), Cory Pfeiffenberger (Complete Healthcare ...

Motesanib inhibits Kit mutations associated with gastrointestinal...

cyberleninka.org

... whose work was funded by Amgen Inc., and Beate Quednau, PhD (Amgen Inc.), for their assistance in the preparation of this manuscript. Author Details.

Verwandte Suchanfragen zu Beate Quednau

Person "Quednau" (5)
Vorname "Beate" (25845)
Name "Quednau" (262)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Beate Quednau und Amgen Person-Info